79
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Increased Burden of Morbidity Over the Life-Course Among Patients with COPD: A Register-Based Cohort Study in Sweden

ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon
Pages 1375-1389 | Received 22 Feb 2024, Accepted 07 May 2024, Published online: 19 Jun 2024

References

  • Chetty U, McLean G, Morrison D, Agur K, Guthrie B, Mercer SW. Chronic obstructive pulmonary disease and comorbidities: a large cross-sectional study in primary care. Br J Gen Pract. 2017;67(658):e321–e328. doi:10.3399/bjgp17X690605
  • Burke H, Wilkinson TMA. Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care. Eur Respir Rev. 30. 160. doi:10.1183/16000617.0041-2021
  • Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
  • Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC.
  • Stallberg B, Janson C, Larsson K, et al. Real-world retrospective cohort study arctic shows burden of comorbidities in Swedish COPD versus non-COPD patients. NPJ Prim Care Respir Med 2018;28(1):33. doi:10.1038/s41533-018-0101-y.
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. doi:10.1186/1471-2458-11-450.
  • Jones RC, Price D, Ryan D, et al. Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. Lancet Respir Med. 2014;2(4):267–276. doi:10.1016/s2213-2600(14)70008-6
  • Ställberg B, Janson C, Johansson G, et al. Management, morbidity and mortality of COPD during an 11-year period: an observational retrospective epidemiological register study in Sweden (PATHOS). Prim Care Respir J. 2014;23(1):38–45. doi:10.4104/pcrj.2013.00106
  • Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register – a sample survey for year 1998. Acta Oncologica. 2009;48(1):27–33. doi:10.1080/02841860802247664
  • Brooke HL, Talbäck M, Hörnblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–773. doi:10.1007/s10654-017-0316-1
  • Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol Apr. 2019;34(4):423–437. doi:10.1007/s10654-019-00511-8
  • Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131(5):1557–1566. doi:10.1378/chest.06-2179
  • U.S. Department of Health and Human Services. The health consequences of smoking: 50 years of progress: a report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centres for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2014.
  • Thomsen M, Nordestgaard BG, Vestbo J, Lange P. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study. Lancet Respir Med. 2013;1(7):543–550. doi:10.1016/s2213-2600(13)70137-1
  • Lindberg A, Larsson LG, Muellerova H, Rönmark E, Lundbäck B. Up-to-date on mortality in COPD - report from the OLIN COPD study. BMC Pulm Med. 2012;12(1):1. doi:10.1186/1471-2466-12-1
  • Divo MJ, Celli BR, Poblador-Plou B, et al. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: evidence from the epichron cohort. PLoS One. 2018;13(2):e0193143. doi:10.1371/journal.pone.0193143
  • Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
  • Wang M, Lin EP-Y, Huang L-C, Li C-Y, Shyr Y, Lai C-H. Mortality of Cardiovascular Events in Patients With COPD and preceding hospitalization for acute exacerbation. Chest. 2020;158(3):973–985. doi:10.1016/j.chest.2020.02.046
  • Inoue D, Watanabe R, Okazaki R. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;11:637–648. doi:10.2147/copd.S79638
  • Ryan CS, Petkov Adler RA, Adler RA. Osteoporosis in men: the value of laboratory testing. Osteoporos Int. 2011;22(6):1845–1853. doi:10.1007/s00198-010-1421-0
  • Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the U.S. population. Tob Control. 2014;23(e2):e147–53. doi:10.1136/tobaccocontrol-2013-051466
  • Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11–s18. doi:10.3949/ccjm.85.s1.03
  • Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: a systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine. 2022;82:104154. doi:10.1016/j.ebiom.2022.104154
  • Dodd JW. Lung disease as a determinant of cognitive decline and dementia. Alzheimers Res Ther. 2015;7(1):32. doi:10.1186/s13195-015-0116-3
  • Higbee D, Granell R, Walton E, Korologou-Linden R, Davey Smith G, Dodd J. Examining the possible causal relationship between lung function, COPD and Alzheimer’s disease: a Mendelian randomisation study. BMJ Open Respir Res. 2021;8(1):1.
  • Kornum JB, Sværke C, Thomsen RW, Lange P, Sørensen HT. Chronic obstructive pulmonary disease and cancer risk: A Danish nationwide cohort study. Respir Med. 2012;106(6):845–852. doi:10.1016/j.rmed.2011.12.009
  • Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer. 2019;145(7):1719–1730. doi:10.1002/ijc.31961.
  • Arafa A, Mostafa A, Navarini AA, Dong J-Y. The association between smoking and risk of skin cancer: a meta-analysis of cohort studies. Cancer Causes Control. 2020;31(8):787–794. doi:10.1007/s10552-020-01319-8
  • Skajaa N, Laugesen K, Horváth-Puhó E, Sørensen HT. Comorbidities and mortality among patients with chronic obstructive pulmonary disease. BMJ Open Respir Res. 2023;10(1):1.
  • Greulich T, Weist BJD, Koczulla AR, et al. Prevalence of comorbidities in COPD patients by disease severity in a German population. Respir Med. 2017;132:132–138. doi:10.1016/j.rmed.2017.10.007
  • Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a lancet commission. Lancet. 2022;400(10356):921–972. doi:10.1016/s0140-6736(22)01273-9.
  • Athlin Å, Lisspers K, Hasselgren M, et al. Diagnostic spirometry in COPD is increasing, a comparison of two Swedish cohorts. NPJ Prim Care Respir Med. 2023;33(1):23. doi:10.1038/s41533-023-00345-8.
  • Inghammar M, Engström G, Löfdahl CG, Egesten A. Validation of a COPD diagnosis from the Swedish Inpatient Registry. Scand J Public Health. 2012;40(8):773–776. doi:10.1177/1403494812463172
  • Spero K, Bayasi G, Beaudry L, Barber KR, Khorfan F. Overdiagnosis of COPD in hospitalized patients. Int J Chron Obstruct Pulmon Dis. 2017;12:2417–2423. doi:10.2147/copd.S139919
  • Ekberg-Aronsson M, Löfdahl K, Nilsson JA, Löfdahl CG, Nilsson PM. Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--A population-based study. Respir Med. 2008;102(1):109–120. doi:10.1016/j.rmed.2007.07.028
  • Serdén L, Lindqvist R, Rosén M. Have DRG-based prospective payment systems influenced the number of secondary diagnoses in health care administrative data? Health Policy. 2003;65(2):101–107. doi:doi:10.1016/S0168-8510(02)00208-7